期刊
CHEMBIOCHEM
卷 17, 期 12, 页码 1138-1141出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201600052
关键词
anticancer; DNA walker; DNAzyme; growth inhibition; oligonucleotides
资金
- U.S. Office of Naval Research National Science Foundation
- National Institutes of Health [UL1TR000006]
- Directorate For Engineering
- Div Of Chem, Bioeng, Env, & Transp Sys [1512537] Funding Source: National Science Foundation
- Div Of Civil, Mechanical, & Manufact Inn
- Directorate For Engineering [1437301, 1055866] Funding Source: National Science Foundation
We demonstrate a DNAzyme-based walker system as a controlled oligonucleotide drug AS1411 release platform for breast cancer treatment. In this system, AS1411 strands are released from fuel strands as a walker moves along its carbon nanotube track. The release rate and amount of anticancer oligonucleotides are controlled by the walker operation. With a walker system embedded within the collagen extracellular matrix, we show that this drug release system can be used for in situ cancer cell growth inhibition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
